期刊文献+

甲基强的松龙抑制实验性自身免疫性脑脊髓炎IL-23/IL-17轴机制研究 被引量:10

Methylprednisolone inhibits IL-23/IL-17 axis in model of acute experimental autoimmune encephalomyelitis
下载PDF
导出
摘要 目的探讨甲基强的松龙(methylprednisolone,MP)对大鼠实验性自身免疫性脑脊髓炎(experimental autoimmuneen cephalomyelitis,EAE)新发现的IL-23/IL-17炎性轴发病机制的影响。方法建立Wistar大鼠EAE动物模型,给予糖皮质激素MP和生理盐水预处理建立MP组和EAE组,并设立正常对照组,RT-PCR法检测大鼠脑组织中白介素-12(interleukin-12,IL-12)和白介素-23(interleukin-23,IL-23)亚基IL-23P19、IL-12P40、IL-12P35及白介素-17(interleukin-17,IL-17)前体毒性T细胞相关抗原8(cytotoxic T lymphocyte-associated antigen8,CTLA-8)的mR-NA表达,用ELISA法检测IL-17水平。结果MP组大鼠脑组织中IL-23P19、IL-12P40、IL-12P35及CTLA-8的mR-NA的表达比EAE组低(P<0.05),IL-17水平也低于EAE组(P<0.05),差异均有统计学意义。结论甲基强的松龙能够抑制IL-23/IL-17轴而起到抗炎治疗作用。 Objective To explore the effects of methylprednisolone on newly IL-23/IL-17 immune axis of rats with acute experimental autoimmune encephalomyelitis (EAE), Methods EAE model was induced in wistar rats,and were respectively treated with methylprednisolone and normal saline as MP group and EAE group. Normal rats were selected as control group, levels of IL-23P19, IL-12P40, IL-12P35, and CTLA-8 mRNA in brain tissue were detected by RT-PCR. The IL-17 level in the brain tissue supernatant was measured by the ELISA method. Results IL-23P19, IL-12P40, IL- 12P35 and CTLA-8 mRNA levels and IL-17 protein levels in brain tissue were significantly decreased in MP treated EAE rats than those in EAE rats (P 〈0. 05). Conclusions Methylprednisolone may exert anti-inflammatory effect through inhibiting IL-23/IL-17 axis.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2008年第6期345-348,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 多发性硬化 实验性自身免疫性脑脊髓炎 甲基强的松龙 IL-23 IL-17 Multiple Sclerosis Experimental Antoimmune Encephalomyelitis Methylprednisolone IL-23 IL-17
  • 相关文献

参考文献19

  • 1Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation [J]. J Clin Invest,2006,116(5):1218- 1222. 被引量:1
  • 2袁宝玉,秦新月,彭国光.PPARγ激动剂对实验性自身免疫性脑脊髓炎钙激活中性蛋白酶表达的影响[J].中国病理生理杂志,2007,23(5):955-958. 被引量:2
  • 3Koh CS, Paterson PY. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor [ J ]. Cell-Immunol 1987,107 ( 1 ) : 52 - 63. 被引量:1
  • 4Gately MK, Renzetti LM, Magram J, et al. The interleukin-12/ interleukin-12-receptor system: role in normal and pathologic immune responses[ J]. Annu Rev Immunol, 1998,16:495 - 521. 被引量:1
  • 5Bartosik-Psujek H,Stelmasiak Z. Correlations between IL-4, IL- 12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients [J]. J Neural Transm, 2005,112 (6) :797 - 803. 被引量:1
  • 6Clerici M ,Saresella M ,Trabattoni D, et al. Single-cell a nalysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease [ J ]. J Neuroimmunol,2001,121 ( 1 - 2) :88 - 101. 被引量:1
  • 7Peltoniemi J, Broberg EK, Halenius A, et al. Immunomodulation by roquinimex decreases the expression of IL-23 (P19)mRNA in the brains of herpes simplec virus type 1 infected BALB/c mice [J]. Clin Exp Immunol,2004,137(2):305 -312. 被引量:1
  • 8angrish CI, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell populatkm that induces autoimmune inflammation [ J ]. J Exp Med ,2005,201 (2) :233 - 240. 被引量:1
  • 9Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain[J]. Nature,2003,421 (6924) :744 -748. 被引量:1
  • 10Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17- producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005, 6(11 ) :1123 -1132. 被引量:1

二级参考文献13

  • 1Schaecher K,Rocchini A,Dinkins J,et al.Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time:increased calpain activity begins with onset of disease[J].J Neuroimmunol,2002,129(1-2):1-9. 被引量:1
  • 2Guyton MK,Sribnick EA,Ray SK,et al.A role for calpain in optic neuritis[J].Ann N Y Acad Sci,2005,1053 (1):48-54. 被引量:1
  • 3Yano T,Kobayashi A,Kurata S,et al.Purification and characterization of cathepsin B mRNA 3'-untranslated-regionbinding protein (CBBP),a protein that represses cathepsin B mRNA translation[J].Eur J Biochem,1997,245(2):260 -265. 被引量:1
  • 4Duvanel CB,Honegger P,Pershadsingh H,et al.Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro[J].J Neurosci Res,2003,71(2):246 -255. 被引量:1
  • 5Shields DC,Schaecher KE,Saido TC.A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme,calpain[J].Proc Natl Acad Sci USA,1999,96(20):11486 -11491. 被引量:1
  • 6Koh CS,Paterson PY.Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor[J].Cell Immunol,1987,107(1):52 -63. 被引量:1
  • 7Mohan R,Heyman RA.Orphan nuclear receptor modulators[J].Curr Top Med Chem,2003,3 (14):1637 -1647. 被引量:1
  • 8Polak PE,Kalinin S,Dello RC,et al.Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis[J].J Neuroimmunol,2005,168(1 -2):65-75. 被引量:1
  • 9Mudaliar S,Henry RR.New oral therapies for type 2 diabetes mellitus:the glitazones or insulin sensitizers[J].Annu Rev Med,2001,52(1):239-257. 被引量:1
  • 10Jiang C,Ting AT,Seed B.PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines[J].Nature,1998,391(6662):82 -86. 被引量:1

共引文献1

同被引文献119

  • 1陈德昌,景炳文,张翔宇,王越波.大黄对肠粘膜屏障的保护作用[J].中国危重病急救医学,1994,6(6):329-331. 被引量:111
  • 2BinGao.Cytokines,STATs and Liver Disease[J].Cellular & Molecular Immunology,2005,2(2):92-100. 被引量:30
  • 3马小彤,吴克复,张秀军,李戈,林永敏,宋玉华.脂多糖和金黄色葡萄球菌对IL-23、IL-12表达的调控[J].中国免疫学杂志,2006,22(1):33-36. 被引量:3
  • 4杨军,李成荣,祖莹,王国兵,李永柏.调节性T细胞在儿童过敏性紫癜发病机制中的作用初探[J].中华儿科杂志,2006,44(6):411-414. 被引量:67
  • 5Courtney A M, Treadaway K, Remington G, et al. Multiple sclerosis [J]. MedClin North Am, 2009, 93(2):451-476, ix-x. 被引量:1
  • 6Tallantyre E C, Bo L, Al-Rawashdeh O, et al. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease [J]. Brain, 2009, 132(Pt 5) : 1190 -1199. 被引量:1
  • 7Fournier A E, GrandPre T, Strittmatter S M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration [ J ]. Nature, 2001, 409 (6818 ) : 341 - 346. 被引量:1
  • 8Satoh J, Onoue H, Arima K, et al. Nogo-A and nogo receptor expres-sion in demyelinating lesions of multiple sclerosis [ J ]. J Neuropathol Exp Neurol, 2005, 64(2) : 129 -138. 被引量:1
  • 9Barrett P N, Meyer H Wachtel I, et al. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay [J]. J Med Virol, 1996, 49(1) : 1 -6. 被引量:1
  • 10Koh C S, Paterson P Y. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeahility in Lewis rats treated with a plasminogen activator inhibitor [J]. Cell Immunol, 1987, 107 (1) : 52-63. 被引量:1

引证文献10

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部